Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung

New England Journal of Medicine

Volumn 316, Issue 15, 1987, Pages 912-918

  Perry, Michael C ^{a,b,c,d,e,f,g,h}   Eaton, Walter L ^{a,b,c,d,e,f,g,h}   Propert, Kathleen J ^{a,b,c,d,e,f,g,h}   Ware, James H ^{a,b,c,d,e,f,g,h}   Zimmer, Bonnie ^{a,b,c,d,e,f,g,h}   Chahinian, A Philippe ^{a,b,c,d,e,f,g,h}   Skarin, Arthur ^{a,b,c,d,e,f,g,h}   Carey, Robert W ^{a,b,c,d,e,f,g,h}   Kreisman, Harvey ^{a,b,c,d,e,f,g,h}   Faulkner, Charles ^{a,b,c,d,e,f,g,h}   Comis, Robert ^{a,b,c,d,e,f,g,h}   Green, Mark R ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF MISSOURI   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^e MOUNT SINAI HOSPITAL   (United States)

^f MCGILL UNIVERSITY   (Canada)

^g FOX CHASE CANCER CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADVERSE DRUG REACTION; ANOREXIA; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; DRUG COMPARISON; DRUG EFFICACY; DRUG SENSITIVITY; DRUG THERAPY; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NAUSEA; PRIORITY JOURNAL; RADIOTHERAPY; RESPIRATORY SYSTEM; SEPSIS; SMALL CELL CARCINOMA; SURVIVAL; THERAPY; TOXICITY; TUMOR; VOMITING;

EID: 0023112256     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198704093161504     Document Type: Article

References (20)

1. Bergsagel D. Feld R. Small-cell lung cancer is still a problem. J Clin Oncol 1984; 2: 1189–91.
2. Greco FA, Oldham RK. Current concepts in cancer. Small-cell lung cancer. N Engl J Med 1979; 301: 355–8.
3. Greco FA, Einhorn LH, Richardson RL. Oldham RK. Small cell lung cancer; progress and perspectives. Semin Oncol 1978; 5: 323–35.
4. Hansen HH. Elliott JA. Patterns of failure in small cell lung cancer: implications for therapy. Recent Results Cancer Res 1984; 92: 43–57.
5. Maurer LH. Tulloh M. Weiss RB, et al. A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 1980; 45: 30–9.
6. Bunn PA Jr. Lichter AS. Glatstein E. Minna JD. Results of recent studies in small cell bronchogenic carcinoma and prospects for future studies. In: Greco FA, Oldham RK. Bunn PA Jr, eds. Small cell lung cancer. New York: Grune & Stratton. 1981:413–46.
7. Morstyn G, Ihde DC, Lichter AS, et al. Small cell lung cancer 1973–1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys 1984; 10: 515–39.
8. Maurer LH. Pajak T. Eaton W, et al. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a phase III Cancer and Leukemia Group B study. J Clin Oncol 1985; 3: 969–76.
9. Kent CH, Brerelon HD, Johnson RE. “Total” therapy for oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1977; 2: 427–32.
10. Aisner J, Whitacre M. VanEcho DA. Wesley M. Wiernik PH. Doxorubicin, cyclophosphamide. and VP16–213 (ACE) in the treatment of small cell lung cancer. Cancer Chemother Pharmacol 1982; 7: 187–93.
11. The World Health Organization histological typing of lung tumours: second edition. Am J Clin Pathol 1982; 77: 123–36.
12. Maurer LH. Pajak TF. Prognostic factors in small cell carcinoma of the lung: a Cancer and Leukemia Group B study. Cancer Treat Rep 1981; 65: 767–74.
13. Armitage P. Statistical methods in medical research. Oxford: Blackwell, 1971.
14. Peto R, Pike MC. Armitage P. et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
15. Cohen MH. Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No. Cancer Treat Rep 1983; 67: 217–21.
16. Cox JD. Combined modality treatment of small cell carcinoma of the lung. In: Wiernik PH, ed. Controversies in oncology. New York: John Wiley. 1982:139–53.
17. Byhardt RW. Cox JD. Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes. Cancer Treat Rep 1983; 67: 209–15.
18. Aisner J. Is combined modality treatment of small cell carcinoma of the lung necessary? In: Wiernik PH, ed. Controversies in oncology. New York: John Wiley, 1982:155–73.
19. Perez CA, Einhorn L, Oldham RK, et al. Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. J Clin Oncol 1984; 2: 1200–8.
20. Salazar OM. Creech RH. “The state of the art” toward defining the role of radiation therapy in the management of small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1980; 6: 1103–17.